De novo Renal Transplantation after Kaposi Sarcoma: Favorable Outcome in a Patient Receiving Sirolimus and Mycophenolate-Based Immunosuppression

• Hauptverfasser: F. Friedersdorff (Verfasst von), M. Giessing (Verfasst von), C. Roller (Verfasst von), D. Baumunk (Verfasst von), S. Deger (Verfasst von), K. Budde (Verfasst von), L. Liefeldt (Verfasst von), V. Hartmann (Verfasst von), T.F. Fuller (Verfasst von)
• Format: Buch
• Veröffentlicht: Karger Publishers, 2010-04-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Immunosuppressive treatment increases the risk of infection and malignancy in organ transplant recipients. We report on a 42-year-old male renal transplant recipient who lost his first graft after reduction of immunosuppressive treatment due to Kaposi sarcoma and who successfully underwent a second...